Literature DB >> 3925490

Effects of apomorphine and haloperidol on "spontaneous" stereotyped licking behaviour in the Cebus monkey.

S Korsgaard, U J Povlsen, A Randrup.   

Abstract

Three recently arrived drug naive Cebus apella monkeys with "spontaneous" stereotyped oral movements were treated with apomorphine and haloperidol using a wide dose range. Low doses of apomorphine (0.05-0.1 mg/kg) suppressed the oral stereotypies without affecting normal behaviour such as grooming and scratching. Higher doses of apomorphine (0.25-1.0 mg/kg) and haloperidol (0.01-0.1 mg/kg) also decreased or abolished the oral stereotypies, but induced generalized stereotypies (apomorphine) or dystonia/parkinsonism (haloperidol), suppressing normal behaviour. The findings indicate that dopamine is involved in these presumably stress-induced (not drug-induced) stereotypies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925490     DOI: 10.1007/bf00428423

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies.

Authors:  D Clark; A Carlsson; S Hjorth; K Svensson; J Engel; D Sanchez
Journal:  Eur J Pharmacol       Date:  1982-09-10       Impact factor: 4.432

2.  Effect of apomorphine and gabaergic drugs in monkeys pretreated with haloperidol.

Authors:  N Bjørndal; J Gerlach; D E Casey; E Christensson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

3.  Behavioural and biochemical effects of chronic treatment with amphetamine in the vervet monkey.

Authors:  R M Ridley; H F Baker; F Owen; A J Cross; T J Crow
Journal:  Neuropharmacology       Date:  1983-04       Impact factor: 5.250

Review 4.  Effect of apomorphine on schizophrenic symptoms.

Authors:  R C Smith; C Tamminga; J M Davis
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

5.  Progressive changes in the acute dyskinetic syndrome as a function of repeated elicitation in squirrel monkeys.

Authors:  R Neale; S Gerhardt; S Fallon; J M Liebman
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.

Authors:  M I Levy; B M Davis; R C Mohs; K S Kendler; A A Mathé; G Trigos; T B Horvath; K L Davis
Journal:  Arch Gen Psychiatry       Date:  1984-05

7.  Clinical effects of apomorphine in schizophrenia.

Authors:  I N Ferrier; E C Johnstone; T J Crow
Journal:  Br J Psychiatry       Date:  1984-04       Impact factor: 9.319

8.  Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.

Authors:  R D Eibergen; K R Carlson
Journal:  Pharmacol Biochem Behav       Date:  1976-08       Impact factor: 3.533

9.  Schizophrenic symptoms improve with apomorphine.

Authors:  C A Tamminga; M H Schaffer; R C Smith; J M Davis
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

Review 10.  Dopamine autoreceptor stimulation: clinical significance.

Authors:  H Y Meltzer
Journal:  Pharmacol Biochem Behav       Date:  1982       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.